Clinical Trial Update: Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Asparaginase Erwinia chrysanthemi in combination with chemotherapy for high-risk adults with newly diagnosed acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Asparaginase Erwinia chrysanthemi (L-asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: City of Hope Medical Center | Conditions: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma | Phase 2 | Status: RECRUITING